These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Donor pretreatment as an adjunct to cadaver renal allotransplantation. Guttman RD; Beaudoin JG; Morehouse DD; Klassen J; Knaack J; Jeffery J; Chassot PG; Abbou CC Transplant Proc; 1975 Mar; 7(1):117-21. PubMed ID: 123373 [No Abstract] [Full Text] [Related]
27. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants. Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685 [TBL] [Abstract][Full Text] [Related]
28. Cadaver Kidney transplantation. Effect of hypotension and donor pretreatment with methylprednisolone and phenoxybenzamine. Toledo-Pereyra LH; Simmons RL; Olson LC; Najarian JS Minn Med; 1979 Mar; 62(3):159-61. PubMed ID: 370540 [No Abstract] [Full Text] [Related]
29. Primary cadaver kidney transplant survival after donor pretreatment with cyclophosphamide and methylprednisolone. Barry JM; Bennett WM Transplantation; 1978 Sep; 26(3):202-3. PubMed ID: 360520 [No Abstract] [Full Text] [Related]
30. Donor pretreatment on perfused cadaver kidneys: experimental observations. Sy G; Taiyebb S; Toledo-Pereyra LH Am Surg; 1981 Jul; 47(7):307-8. PubMed ID: 7020513 [No Abstract] [Full Text] [Related]
31. The LifeLink Foundation and cadaver kidney transplantation in Tampa. LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL Clin Transpl; 1999; ():149-58. PubMed ID: 11038633 [TBL] [Abstract][Full Text] [Related]
32. Impact of donor age on renal allograft function and survival. Resende L; Guerra J; Santana A; Mil-Homens C; Abreu F; da Costa AG Transplant Proc; 2009 Apr; 41(3):794-6. PubMed ID: 19376354 [TBL] [Abstract][Full Text] [Related]
33. Effect of immunologic donor pretreatment on survival of perfused canine renal allografts. Pechan W; Novick AC; Stowe N; Magnusson M; Straffon RA Invest Urol; 1980 Jul; 18(1):74-6. PubMed ID: 6997225 [TBL] [Abstract][Full Text] [Related]
34. Impact of pre-existing donor hypertension and diabetes mellitus on cadaveric renal transplant outcomes. Ojo AO; Leichtman AB; Punch JD; Hanson JA; Dickinson DM; Wolfe RA; Port FK; Agodoa LY Am J Kidney Dis; 2000 Jul; 36(1):153-9. PubMed ID: 10873885 [TBL] [Abstract][Full Text] [Related]
35. Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry. Takemoto S; Terasaki PI; Cecka JM; Cho YW; Gjertson DW N Engl J Med; 1992 Sep; 327(12):834-9. PubMed ID: 1508242 [TBL] [Abstract][Full Text] [Related]
37. Prolongation of canine allograft survival with donor pretreatment. Brom HL; van Breda Vriesman PJ; Terpstra JL Kidney Int; 1982 Feb; 21(2):323-9. PubMed ID: 6803060 [TBL] [Abstract][Full Text] [Related]
38. Skin and renal rabbit allograft rejection following large pulse doses of methylprednisolone. Friedman EA; Beyer MM Transplant Proc; 1975 Mar; 7(1):67-72. PubMed ID: 1091047 [No Abstract] [Full Text] [Related]
39. The fate of glomerular mesangial IgA deposition in the donated kidney after allograft transplantation. Ji S; Liu M; Chen J; Yin L; Sha G; Chen H; Liu Z; Li L Clin Transplant; 2004 Oct; 18(5):536-40. PubMed ID: 15344956 [TBL] [Abstract][Full Text] [Related]
40. The enhancing effect of donor pretreatment and low dose immunosuppression in dogs. Swistel AJ; McCabe RE; Lorieo DR; Wildstein A; Pierce JC; Fitzpatrick HF Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():93-5. PubMed ID: 386328 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]